These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29671244)

  • 41. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overdose from designer benzodiazepine Diclazepam.
    Runnstrom M; Kalra SS; Lascano J; Patel DC
    QJM; 2020 Feb; 113(2):122-124. PubMed ID: 31593281
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
    Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
    Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.
    Orsolini L; Corkery JM; Chiappini S; Guirguis A; Vento A; De Berardis D; Papanti D; Schifano F
    Curr Neuropharmacol; 2020; 18(9):809-837. PubMed ID: 31933443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring the Attractiveness of New Psychoactive Substances (NPS) among Experienced Drug Users.
    van Amsterdam JG; Nabben T; Keiman D; Haanschoten G; Korf D
    J Psychoactive Drugs; 2015; 47(3):177-81. PubMed ID: 26098724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rational use of anxiolytic/sedative drugs.
    Lader M; Petursson H
    Drugs; 1983 May; 25(5):514-28. PubMed ID: 6134609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Legal highs" on the net-Evaluation of UK-based Websites, products and product information.
    Schmidt MM; Sharma A; Schifano F; Feinmann C
    Forensic Sci Int; 2011 Mar; 206(1-3):92-7. PubMed ID: 20650576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.
    Ho JH; Bailey GP; Archer JR; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1185-96. PubMed ID: 26195274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography.
    Tomková J; Švidrnoch M; Maier V; Ondra P
    J Sep Sci; 2017 May; 40(9):2037-2044. PubMed ID: 28266783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The blood-to-plasma ratio and predicted GABA
    Manchester KR; Waters L; Haider S; Maskell PD
    Forensic Toxicol; 2022 Jul; 40(2):349-356. PubMed ID: 36454409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
    Brunetti P; Giorgetti R; Tagliabracci A; Huestis MA; Busardò FP
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam.
    Moosmann B; Bisel P; Franz F; Huppertz LM; Auwärter V
    J Mass Spectrom; 2016 Nov; 51(11):1080-1089. PubMed ID: 27535017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
    Van Hout MC; Hearne E
    Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonmedical use of benzodiazepines and Z-drugs in the UK.
    Hockenhull J; Black JC; Haynes CM; Rockhill K; Dargan PI; Dart RC; Wood DM
    Br J Clin Pharmacol; 2021 Apr; 87(4):1676-1683. PubMed ID: 32472941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of Flubromazepam Positional Isomers for Forensic Analysis.
    Ligon ES; Nawyn J; Jones LV; Allred BM; Reinhardt DV; France S
    J Org Chem; 2019 Aug; 84(16):10280-10291. PubMed ID: 31328518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of the Psychoactive Substances Act 2016 on the online availability of MDMB-CHMICA.
    Haden M; Wood DM; Dargan PI
    QJM; 2017 Oct; 110(10):619-622. PubMed ID: 28339898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.
    Edinoff AN; Nix CA; Odisho AS; Babin CP; Derouen AG; Lutfallah SC; Cornett EM; Murnane KS; Kaye AM; Kaye AD
    Neurol Int; 2022 Aug; 14(3):648-663. PubMed ID: 35997362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Benzodiazepines to people with substance abuse problems?].
    Waal H; Bramness JG
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of benzodiazepine dependence].
    Soyka M; München B
    Fortschr Neurol Psychiatr; 2019 Apr; 87(4):259-270. PubMed ID: 30999380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.